blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2139498

EP2139498 - METHODS FOR DETECTING A NATURAL KILLER (NK) CELL-MEDIATED IMMUNE RESPONSE AND AN INCREASE IN NK CELL ACTIVITY [Right-click to bookmark this link]
Former [2010/01]METHODS FOR INDUCING A NATURAL KILLER (NK) CELL-MEDIATED IMMUNE RESPONSE AND FOR INCREASING NK CELL ACTIVITY
[2014/09]
StatusNo opposition filed within time limit
Status updated on  22.01.2016
Database last updated on 06.07.2024
Most recent event   Tooltip08.12.2017Lapse of the patent in a contracting state
New state(s): LU		published on 10.01.2018  [2018/02]
Applicant(s)For all designated states
DENDREON PHARMACEUTICALS, INC.
400 Somerset Corporate Boulevard
Bridgewater, NJ 08807 / US
[2015/38]
Former [2015/37]For all designated states
Drone Acquisition Sub Inc.
400 Somerset Corporate Boulevard
Bridgewater, NJ 08807 / US
Former [2010/01]For all designated states
DENDREON CORPORATION
3005 First Avenue
Seattle, Washington 98121 / US
Inventor(s)01 / SHEIKH, Nadeem
5821 45th Avenue NE
Seattle, WA 98105 / US
02 / JONES, Lori, A.
3216 NE 86th Street
Seattle, WA 98115 / US
 [2010/01]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2015/12]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2014/14]Vossius & Partner
P.O. Box 86 07 67
81634 München / DE
Former [2010/01]Barth, Renate, et al
Vossius & Partner Siebertstrasse 4
81675 München / DE
Application number, filing date08727066.621.03.2008
[2010/01]
WO2008US03755
Priority number, dateUS20070896461P22.03.2007         Original published format: US 896461 P
[2010/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008118369
Date:02.10.2008
Language:EN
[2008/40]
Type: A2 Application without search report 
No.:EP2139498
Date:06.01.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 02.10.2008 takes the place of the publication of the European patent application.
[2010/01]
Type: B1 Patent specification 
No.:EP2139498
Date:18.03.2015
Language:EN
[2015/12]
Search report(s)International search report - published on:EP11.12.2008
ClassificationIPC:A61K35/14, A61K38/19, A61K38/57, A61P35/00, G01N33/50, G01N33/569
[2010/01]
CPC:
G01N33/5047 (EP,US); A61K38/193 (EP,US); A61K38/57 (EP,US);
A61P35/00 (EP); A61P37/02 (EP); G01N2333/535 (EP,US);
G01N2800/52 (EP,US) (-)
C-Set:
A61K38/193, A61K2300/00 (US,EP);
A61K38/57, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/01]
Extension statesAL22.10.2009
BA22.10.2009
MK22.10.2009
RS22.10.2009
TitleGerman:VERFAHREN ZUM NACHWEIS EINER NATÜRLICHEN KILLER (NK) ZELL-VERMITTELTEN IMMUNANTWORT UND EINER ERHÖHUNG DER NK-ZELLAKTIVITÄT[2014/09]
English:METHODS FOR DETECTING A NATURAL KILLER (NK) CELL-MEDIATED IMMUNE RESPONSE AND AN INCREASE IN NK CELL ACTIVITY[2014/09]
French:PROCÉDÉS DE DETECTION D'UNE RÉPONSE IMMUNITAIRE MÉDIÉE PAR DES CELLULES TUEUSES NATURELLES (NK) ET D'UNE AUGMENTATION DE L'ACTIVITÉ DES CELLULES NK[2014/09]
Former [2010/01]VERFAHREN ZUR AUSLÖSUNG EINER NATÜRLICHEN KILLER (NK) ZELL-VERMITTELTEN IMMUNANTWORT UND ZUR ERHÖHUNG DER NK-ZELLAKTIVITÄT
Former [2010/01]METHODS FOR INDUCING A NATURAL KILLER (NK) CELL-MEDIATED IMMUNE RESPONSE AND FOR INCREASING NK CELL ACTIVITY
Former [2010/01]PROCÉDÉS D'INDUCTION D'UNE RÉPONSE IMMUNITAIRE MÉDIÉE PAR DES CELLULES TUEUSES NATURELLES (NK) ET D'AUGMENTATION DE L'ACTIVITÉ DES CELLULES NK
Entry into regional phase22.10.2009National basic fee paid 
22.10.2009Designation fee(s) paid 
22.10.2009Examination fee paid 
Examination procedure22.10.2009Amendment by applicant (claims and/or description)
22.10.2009Examination requested  [2010/01]
05.02.2010Despatch of a communication from the examining division (Time limit: M06)
13.08.2010Reply to a communication from the examining division
16.06.2011Despatch of a communication from the examining division (Time limit: M04)
13.10.2011Reply to a communication from the examining division
27.01.2014Cancellation of oral proceeding that was planned for 04.02.2014
04.02.2014Date of oral proceedings (cancelled)
26.03.2014Communication of intention to grant the patent
04.08.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.08.2014Fee for grant paid
04.08.2014Fee for publishing/printing paid
30.09.2014Communication of intention to grant the patent
03.02.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.02.2010
Opposition(s)21.12.2015No opposition filed within time limit [2016/08]
Fees paidRenewal fee
15.03.2010Renewal fee patent year 03
15.03.2011Renewal fee patent year 04
14.03.2012Renewal fee patent year 05
11.03.2013Renewal fee patent year 06
12.03.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.03.2008
AT18.03.2015
BE18.03.2015
BG18.03.2015
CY18.03.2015
CZ18.03.2015
DK18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
MC18.03.2015
MT18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SI18.03.2015
SK18.03.2015
TR18.03.2015
LU21.03.2015
CH31.03.2015
LI31.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
[2018/02]
Former [2017/39]HU21.03.2008
AT18.03.2015
BE18.03.2015
BG18.03.2015
CY18.03.2015
CZ18.03.2015
DK18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
MC18.03.2015
MT18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SI18.03.2015
SK18.03.2015
TR18.03.2015
CH31.03.2015
LI31.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2017/03]AT18.03.2015
BE18.03.2015
CZ18.03.2015
DK18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
MC18.03.2015
MT18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SI18.03.2015
SK18.03.2015
CH31.03.2015
LI31.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2016/37]AT18.03.2015
BE18.03.2015
CZ18.03.2015
DK18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
MC18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SI18.03.2015
SK18.03.2015
CH31.03.2015
LI31.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2016/12]AT18.03.2015
CZ18.03.2015
DK18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
MC18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SI18.03.2015
SK18.03.2015
CH31.03.2015
LI31.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2016/07]AT18.03.2015
CZ18.03.2015
DK18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
MC18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SK18.03.2015
CH31.03.2015
LI31.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2016/06]AT18.03.2015
CZ18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
MC18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SK18.03.2015
CH31.03.2015
LI31.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2016/03]AT18.03.2015
CZ18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
IT18.03.2015
LT18.03.2015
LV18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SK18.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2015/51]AT18.03.2015
CZ18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
LT18.03.2015
LV18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SK18.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2015/50]CZ18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
LT18.03.2015
LV18.03.2015
PL18.03.2015
RO18.03.2015
SE18.03.2015
SK18.03.2015
NO18.06.2015
GR19.06.2015
IS18.07.2015
PT20.07.2015
Former [2015/49]CZ18.03.2015
EE18.03.2015
ES18.03.2015
FI18.03.2015
HR18.03.2015
LT18.03.2015
LV18.03.2015
RO18.03.2015
SE18.03.2015
SK18.03.2015
NO18.06.2015
GR19.06.2015
PT20.07.2015
Former [2015/39]FI18.03.2015
HR18.03.2015
LT18.03.2015
LV18.03.2015
SE18.03.2015
NO18.06.2015
GR19.06.2015
Former [2015/37]FI18.03.2015
HR18.03.2015
LT18.03.2015
SE18.03.2015
NO18.06.2015
GR19.06.2015
Former [2015/36]FI18.03.2015
HR18.03.2015
LT18.03.2015
SE18.03.2015
NO18.06.2015
Former [2015/35]LT18.03.2015
NO18.06.2015
Cited inInternational search[Y]WO0127245  (DENDREON CORP [US]) [Y] 1-28 * page 2, line 1 - line 22 * * page 7, line 14 - line 28 *;
 [DXY]US5976546  (LAUS REINER [US], et al) [DX] 26-28 * column 2, line 53 - line 67; example -; claim - * * column 4, line 1 - line 18 * [Y] 1-28;
 [DY]  - MORETTA A ET AL, "ACTIVATING RECEPTORS AND CORECEPTORS INVOLVED IN HUMAN NATURAL KILLER CELL-MEDIATED CYTOLYSIS", ANNUAL REVIEW OF IMMUNOLOGY, ANNUAL REVIEWS INC, US, (20010101), vol. 19, ISSN 0732-0582, pages 197 - 223, XP008016880 [DY] 1-28 * page 203 *

DOI:   http://dx.doi.org/10.1146/annurev.immunol.19.1.197
 [XY]  - VIDOVIC DAMIR ET AL, "Antitumor vaccination with her-2-derived recombinant antigens.", INTERNATIONAL JOURNAL OF CANCER, (20021220), vol. 102, no. 6, ISSN 0020-7136, pages 660 - 664, XP009103684 [X] 26-28 * abstract * [Y] 1-28

DOI:   http://dx.doi.org/10.1002/ijc.10785
 [Y]  - WILLIAMS M D ET AL, "Production of Recombinant DTctGMCSF Fusion Toxin in a Baculovirus Expression Vector System for Biotherapy of GMCSF-Receptor Positive Hematologic Malignancies", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (19980701), vol. 13, no. 2, ISSN 1046-5928, pages 210 - 221, XP004445236 [Y] 1-28 * abstract *

DOI:   http://dx.doi.org/10.1006/prep.1998.0900
 [Y]  - HELGUERA GUSTAVO ET AL, "Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors", MOLECULAR CANCER THERAPEUTICS, (200604), vol. 5, no. 4, ISSN 1535-7163, pages 1029 - 1040, XP002490883 [Y] 1-28 * Abstract; page 1036, column 2, paragraph 2 - page 1038, paragraph 1 *

DOI:   http://dx.doi.org/10.1158/1535-7163.MCT-05-0488
 [Y]  - REIS E SOUSA CAETANO ET AL, "In vivo microbial stimulation induces rapid CD40 ligand-independence production of interleukin 12 by dendritic cells and their redistribution to T cell areas", JOURNAL OF EXPERIMENTAL MEDICINE, (19971201), vol. 186, no. 11, ISSN 0022-1007, pages 1819 - 1829, XP002491253 [Y] 1-28 * page 1819, column 1 *

DOI:   http://dx.doi.org/10.1084/jem.186.11.1819
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.